Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
11
Number of overlapping holdings
16.7%
% of HART's 75 holdings also in HRTS
27.5%
% of HRTS's 41 holdings also in HART
Overlap by Weight
Sector Drift (HART minus HRTS)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in HART |
Weight in HRTS |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 5.4% | 10.9% | 5.4% |
|
ABBOTT LABORATORIES | 5.7% | 4.0% | 4.0% |
 |
ASTRAZENECA PLC | 5.6% | 4.0% | 4.0% |
 |
NOVO NORDISK A/S-B | 4.0% | 3.9% | 3.9% |
 |
NOVARTIS AG | 5.3% | 3.1% | 3.1% |
Position Highlights (Non-Overlapping Exposures)
HART Overweight Relative to HRTS
|
JOHNSON & JOHNSON | 5.3% |
|
ALPHABET INC. CLASS A | 5.0% |
|
PFIZER INC | 5.0% |
|
APPLE INC | 4.9% |
 |
SANOFI-AVENTIS | 4.0% |
|
ELEVANCE HEALTH INC | 2.8% |
|
BRISTOL-MYERS SQUIBB CO | 2.8% |
|
NIKE INC -CL B | 2.7% |
 |
MEDTRONIC PLC | 2.4% |
|
BOSTON SCIENTIFIC CORP | 2.3% |
HART Underweight Relative to HRTS
|
UNITEDHEALTH GROUP INC | -5.6% |
|
ELI LILLY & CO | -5.6% |
|
BRIDGEBIO PHARMA, INC. | -4.3% |
|
ROCHE HOLDINGS LTD-SPONS ADR | -3.9% |
|
VERTEX PHARMACEUTICALS INC | -3.6% |
|
GILEAD SCIENCES INC | -3.1% |
|
THERMO FISHER SCIENTIFIC INC | -2.8% |
|
CRINETICS PHARMACEUTICALS INC | -2.8% |
|
MERCK & CO. INC. | -2.5% |
 |
CHUGAI PHARMACEUTICAL CO LTD | -2.3% |